483 KITE PHARMA Jun 2017

483 KITE PHARMA Jun 2017

Donald Ertel FDA, Michael Havert FDA, Arie Menachem FDA, Graeme Price FDA, Wei Wang FDA$119.00 - Available Now

FDA investigators audited the KITE PHARMA - El Segundo, CA, United States facility and issued inspectional observations (via FDA 483) on 16 Jun 2017.

Product details

  • Category: Biologics
  • Inspection end: 16 Jun 2017
  • Location: El Segundo, United States
  • FEI: 3012583739
Add To Cart